Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

164 та иш

Иш: Invisible influencers: the tumor microbiome’s impact on immunotherapy in colorectal cancer (CRC)

  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

    Мақола20176 иқтибос
    ABI

  2. Regulatory mechanisms of PD-1/PD-L1 in cancers

    Xin Lin, Kuan Kang, Pan Chen +5

    Мақола20245 иқтибос
    ABI

  3. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

    Мақола20175 иқтибос
    ABI

  4. Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4

    Madhukumar Venkatesh, Subhajit Mukherjee, Hongwei Wang +16

    Мақола20143 иқтибос
    ABI

  5. Innate and adaptive immune cells in the tumor microenvironment

    Thomas F. Gajewski, Hans Schreiber, Yang‐Xin Fu

    Шарҳ мақола20133 иқтибос
    ABI

  6. A human gut microbial gene catalogue established by metagenomic sequencing

    Junjie Qin, Ruiqiang Li, Jeroen Raes +50

    Мақола20103 иқтибос
    ABI

  7. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35

    Мақола20153 иқтибос
    ABI

  8. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

    Vyara Matson, Jessica Fessler, Riyue Bao +5

    Мақола20183 иқтибос
    ABI

  9. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

    Мақола20203 иқтибос
    ABI

  10. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

    Diwakar Davar, Amiran Dzutsev, John A. McCulloch +29

    Мақола20213 иқтибос
    ABI

  11. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

    Takeshi Tanoue, Satoru Morita, Damian R. Plichta +25

    Мақола20192 иқтибос
    ABI

  12. Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant

    Zachariah DeFilipp, Patricia P. Bloom, Mariam Torres Soto +7

    Мақола20192 иқтибос
    ABI

  13. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

    S Deleu, Kathleen Machiels, Jeroen Raes +2

    Шарҳ мақола20212 иқтибос
    ABI

  14. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

    Ara Koh, Filipe De Vadder, Petia Kovatcheva‐Datchary +1

    Шарҳ мақола20162 иқтибос
    ABI

  15. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma

    Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli

    Шарҳ мақола20212 иқтибос
    ABI

  16. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

    William R. Wikoff, Andrew Anfora, Jun Liu +4

    Мақола20092 иқтибос
    ABI

  17. Microbiota: a key orchestrator of cancer therapy

    Soumen Roy, Giorgio Trinchieri

    Шарҳ мақола20172 иқтибос
    ABI

  18. Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer

    Susan Bullman, Chandra Sekhar Pedamallu, Ewa Sicińska +26

    Мақола20172 иқтибос
    ABI

  19. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

    Mackenzie Bender, Alex McPherson, Catherine M. Phelps +22

    Мақола20232 иқтибос
    ABI

  20. <i>Roseburia intestinalis</i> generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 <sup>+</sup> T cells

    Xing Kang, Changan Liu, Yanqiang Ding +7

    Мақола20232 иқтибос
    ABI

  21. Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer

    Pasquale Marino, Mariangela Mininni, Giovanni Deiana +7

    Мақола20242 иқтибос
    ABI

  22. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment

    Jiachun Lian, Yanfang Liang, Hailiang Zhang +5

    Шарҳ мақола20222 иқтибос
    ABI

  23. Nanoparticle biointerfacing by platelet membrane cloaking

    Che‐Ming Jack Hu, Ronnie H. Fang, Kuei-Chun Wang +19

    Мақола20152 иқтибос
    ABI

  24. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation

    Marta Wlodarska, Chengwei Luo, Raivo Kolde +19

    Мақола20172 иқтибос
    ABI

  25. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota

    Danfeng Chen, Duochen Jin, Shumin Huang +12

    Мақола20192 иқтибос
    ABI